Adaptive promising zone design for cancer immunotherapy with heterogeneous delayed treatment effect-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adaptive promising zone design for cancer immunotherapy with heterogeneous delayed treatment effect

Published:2024-04-14 Issue: Volume: Page:1-20
ISSN:1054-3406
Container-title:Journal of Biopharmaceutical Statistics
language:en
Short-container-title:Journal of Biopharmaceutical Statistics

Author:

Li Bosheng¹²,Yan Fangrong¹,Jiang Depeng²³^ORCID

Affiliation:

1. Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China

2. Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada

3. School of Public Health, Southeast University, Nanjing, China

Funder

Natural Sciences and Engineering Research Council of Canada

Canadian Institute for Health Research (CIHR) Project Grant

National Natural Science Foundation

Bosheng Li from China Scholarship Council

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10543406.2024.2341674

Reference46 articles.

1. Albert, J., and J. Hu. 2019. Probability and Bayesian Modeling. New York: Chapman and Hall/CRC.

2. Bayesian survival analysis with BUGS

3. Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

4. Improved Endpoints for Cancer Immunotherapy Trials

5. A comparison of two simple hazard ratio estimators based on the logrank test

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP